Mayank Mamtani

Stock Analyst at B. Riley Securities

(1.28)
# 1634
Out of 5,329 analysts
174
Total ratings
35.29%
Success rate
10.57%
Average return
46 Stocks
Name Action PT Current % Upside Ratings Updated
HROW Harrow
Maintains: Buy
69 65
25.04 159.58% 2 Apr 1, 2025
VXRT Vaxart
Maintains: Buy
3 2
0.43 365.12% 6 Mar 27, 2025
TRVI Trevi Therapeutics
Reiterates: Strong Buy
11 20
6.92 189.02% 3 Mar 19, 2025
LCTX Lineage Cell Therape...
Maintains: Buy
4 3
0.48 525% 2 Mar 14, 2025
DNLI Denali Therapeutics
Reiterates: Buy
38 35
16.11 117.26% 2 Mar 5, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
51 38
14.06 170.27% 7 Feb 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
109 96
28.71 234.38% 2 Feb 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
4
0.78 412.82% 1 Jan 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
1 2
0.45 233.33% 3 Dec 19, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
194 236
326.72 -27.77% 11 Nov 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Strong Buy
23 26
6.42 304.98% 19 Oct 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
3 1
n/a n/a 4 Oct 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
33
13.54 143.72% 1 Sep 19, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
20 20
5.2 284.62% 9 Aug 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
29 34
45.41 -25.13% 13 Aug 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
18 5
1.7 194.12% 1 Jul 31, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
122 92
43.03 113.8% 3 Jun 4, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
29 33
n/a n/a 7 Feb 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
8 4
4.12 -2.91% 3 Dec 20, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
7 4
n/a n/a 5 Nov 22, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
140
5.14 2623.74% 1 Oct 13, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
15 19
n/a n/a 11 Sep 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
210 90
3.79 2274.67% 5 Apr 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
160
2.87 5474.91% 1 Mar 29, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
2 1
n/a n/a 4 Nov 16, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
11 5
2.16 131.48% 3 Aug 19, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
58 44
1.62 2616.05% 4 Aug 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
120 90
1.75 5042.86% 4 Jul 14, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
14 7
7.6 -7.89% 3 May 24, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
600 450
n/a n/a 1 Mar 29, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
850 500
n/a n/a 1 Mar 23, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
1
n/a n/a 6 Mar 22, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
10 8
n/a n/a 2 Mar 18, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
23040 15360
n/a n/a 2 Mar 14, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
9750 4500
1.11 405305.41% 3 Jan 24, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
500 270
0.88 30581.82% 2 Nov 30, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
200
n/a n/a 1 May 27, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
138 77
12.54 514.04% 2 Jan 15, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
96
n/a n/a 2 Jul 6, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
1980 1440
1.29 111527.91% 3 May 22, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
8 4
1.29 210.08% 2 Apr 3, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
70 30
n/a n/a 2 Apr 1, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
47 39
89.97 -56.65% 2 Mar 18, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
22 11
1.51 628.48% 1 Mar 13, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
43 34
4.07 735.38% 1 Mar 13, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
14 20
n/a n/a 1 Dec 10, 2019